Skip to main content

Peer Review reports

From: Randomized, open-label, comparative phase IV study on the bioavailability of Ciclosporin Pro (Teva) versus Sandimmun® Optoral (Novartis) under fasting versus fed conditions in patients with stable renal transplants

Original Submission
18 Mar 2018 Submitted Original manuscript
3 Sep 2018 Reviewed Reviewer Report - Zheng Jiao
10 Sep 2018 Reviewed Reviewer Report - charat thongprayoon
11 Sep 2018 Reviewed Reviewer Report - Cheng Xue
24 Oct 2018 Author responded Author comments - Anja Gäckler
Resubmission - Version 2
24 Oct 2018 Submitted Manuscript version 2
10 Nov 2018 Reviewed Reviewer Report - Zheng Jiao
12 Dec 2018 Reviewed Reviewer Report - Research Square
1 Jan 2019 Author responded Author comments - Anja Gäckler
Resubmission - Version 3
1 Jan 2019 Submitted Manuscript version 3
18 Jan 2019 Reviewed Reviewer Report - Research Square
28 Feb 2019 Author responded Author comments - Anja Gäckler
Resubmission - Version 4
28 Feb 2019 Submitted Manuscript version 4
15 Apr 2019 Author responded Author comments - Anja Gäckler
Resubmission - Version 5
15 Apr 2019 Submitted Manuscript version 5
Publishing
17 Apr 2019 Editorially accepted
14 May 2019 Article published 10.1186/s12882-019-1340-z

You can find further information about peer review here.

Back to article page